XClose

RESEARCH DOMAINS

PERSONALISED MEDICINE

Home bam
Menu

Personalised Medicine News

Improving clinical trials with machine learning

Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.

Published: Nov 15, 2017 10:15:08 AM

Sex differences important for medical research

The sex of animals frequently has an effect in biomedical research and therefore should be considered in scientific studies, according to UCL scientists.

Published: Jun 26, 2017 4:18:22 PM

Type 2 diabetes genetic mapping identifies new ‘loci’

Scientists are closer to understanding the genetic causes of type 2 diabetes by identifying 111 new chromosome locations (‘loci’) on the human genome that indicate susceptibility to the disease, according to a UCL-led study in collaboration with Imperial College London.

Published: May 4, 2017 5:32:57 PM

How gut bacteria change cancer drug activity

The activity of cancer drugs changes depending on the types of microbes living in the gut, according to a UCL-led study into how nematode worms and their microbes process drugs and nutrients.

Published: Apr 20, 2017 5:02:48 PM

UCL part of new £100 million Rosalind Franklin Institute

UCL is involved in the Rosalind Franklin Institute (RFI) – a major new £100 million investment by the government into the development of an innovative multi-disciplinary science and technology research centre.

Published: Feb 23, 2017 1:22:00 PM

'Brute force' can overcome antibiotic resistance

Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.

Published: Feb 3, 2017 3:16:25 PM

Light therapy effectively treats early prostate cancer

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.

Published: Dec 20, 2016 9:29:15 AM

Pain sensors specialised for specific sensations

Many pain-sensing nerves in the body are thought to respond to all types of ‘painful events’, but new UCL research in mice reveals that in fact most are specialised to respond to specific types such as heat, cold or mechanical pain.

Published: Nov 14, 2016 11:14:30 AM

‘Middle England’ faces lowest psychosis risk

The risk of developing a psychotic disorder such as schizophrenia is highest for young people, men, ethnic minorities and people living in urban areas and poorer neighbourhoods, finds a new study by UCL and the University of Cambridge.

Published: Oct 24, 2016 5:24:25 PM

View all articles